A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2017-05-16
Summary
This is an observational study to be conducted at approximately 25 sites in the United States. Approximately 25 subjects with severe obstructive CF lung disease (FVC \<40% predicted) will be enrolled.
Conditions
Sponsors & Collaborators
-
Genentech, Inc.
lead INDUSTRY
Principal Investigators
-
Morris Cheeks, M.D. · Genentech, Inc.
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-10-31
- Primary Completion
- 2004-06-30
- Completion
- 2004-06-30
More Related Trials
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
NCT03138772 ·Status: COMPLETED
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556 ·Status: ACTIVE_NOT_RECRUITING
-
Non Invasive Ventilation During Physical Training in Cystic Fibrosis
NCT02684552 ·Status: COMPLETED ·Phase: NA
-
Remotely Supervised Exercise for Adults With Cystic Fibrosis
NCT05173194 ·Status: COMPLETED ·Phase: NA
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR
NCT06184763 ·Status: ACTIVE_NOT_RECRUITING
-
Markers of Osteoporosis in Cystic Fibrosis
NCT03921060 ·Status: RECRUITING ·Phase: PHASE4
-
Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis
NCT02994017 ·Status: COMPLETED ·Phase: NA
-
Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
NCT05899556 ·Status: NOT_YET_RECRUITING
-
Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis
NCT02566044 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000
NCT01651455 ·Status: COMPLETED
-
Assessment of Cognitive Function and Exercise Capacity in Cystic Fibrosis
NCT06175182 ·Status: COMPLETED
-
Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 ·Status: ACTIVE_NOT_RECRUITING
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic Fibrosis
NCT06565832 ·Status: COMPLETED ·Phase: NA
-
Airway Secretion Clearance in Cystic Fibrosis
NCT00839644 ·Status: TERMINATED ·Phase: NA
-
Video Telehealth Exercise Training in Cystic Fibrosis
NCT04680403 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls.
NCT03524859 ·Status: COMPLETED
-
Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 ·Status: COMPLETED
-
Use of Personal Fitness Device in Adult (> 21 Years Old) Patients With Cystic Fibrosis
NCT03122418 ·Status: COMPLETED ·Phase: NA
-
The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis
NCT00557089 ·Status: COMPLETED ·Phase: PHASE4
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation
NCT03068312 ·Status: COMPLETED ·Phase: PHASE3